Safety and Efficacy of Multiple 16-week Courses of Topical Imiquimod for the Treatment of Large Areas of Skin Involved with Actinic Keratoses
about
Comprehensive management of actinic keratoses: practical integration of available therapies with a review of a newer treatment approach.Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancerTherapeutic Effects of Methanol Extract from Euphorbia kansui Radix on Imiquimod-Induced Psoriasis.
P2860
Safety and Efficacy of Multiple 16-week Courses of Topical Imiquimod for the Treatment of Large Areas of Skin Involved with Actinic Keratoses
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Safety and Efficacy of Multipl ...... nvolved with Actinic Keratoses
@ast
Safety and Efficacy of Multipl ...... nvolved with Actinic Keratoses
@en
Safety and Efficacy of Multipl ...... nvolved with Actinic Keratoses
@nl
type
label
Safety and Efficacy of Multipl ...... nvolved with Actinic Keratoses
@ast
Safety and Efficacy of Multipl ...... nvolved with Actinic Keratoses
@en
Safety and Efficacy of Multipl ...... nvolved with Actinic Keratoses
@nl
prefLabel
Safety and Efficacy of Multipl ...... nvolved with Actinic Keratoses
@ast
Safety and Efficacy of Multipl ...... nvolved with Actinic Keratoses
@en
Safety and Efficacy of Multipl ...... nvolved with Actinic Keratoses
@nl
P2093
P2860
P1476
Safety and Efficacy of Multipl ...... nvolved with Actinic Keratoses
@en
P2093
Barry Leshin
Howard Sofen
James Kulp
James Q Del Rosso
Sharon Levy
P2860
P577
2009-04-01T00:00:00Z